Antibe Therapeutics Inc.
-
Head Office:
15 Prince Arthur Ave, Toronto, ONT M5R1B2 CAN -
Reporting Since:
2013-06-10
Previous Names:
Antibe Therapeutics Inc.
Issuer Status:
In Default as of 2024-07-03
Year End:
March 31Principal Regulator:
OntarioDefault History
| Period of Default | Default Code | Default From | Default To |
|---|---|---|---|
|
Q3 2024-12-31
|
1b.,1c.,1e.,3
|
2025-04-28
|
|
|
Q2 2024-09-30
|
1b.,1c.,1e.,3
|
2025-04-28
|
|
|
Q1 2024-06-30
|
1b.,1c.,1e.,3
|
2025-04-28
|
|
|
A 2024-03-31
|
1a.,1c.,1e.,3
|
2024-07-03
|
|
|
AIF 2024-03-31
|
1d.,3
|
2024-07-03
|
Historical Exempt Distributions
Exempt Distribution filings made after 25-July-2023 can be viewed in SEDAR+
| Exemption | Document Type | Distribution From | Distribution To | $ Amount Raised | Filing Date |
|---|---|---|---|---|---|
|
NI 45-106 2.3, NI 45-106 2.5
|
2016-12-15
|
2016-12-21
|
2709495.0000
|
2016-12-23
|
|
|
NI. 45-106, 2.3(1)
|
2016-06-10
|
2016-06-20
|
1455000.0000
|
2016-06-21
|
|
|
NI. 45-106, 2.3(1)
|
2015-12-23
|
2015-12-23
|
450000.0000
|
2016-01-04
|
|
|
NI. 45-106, 2.3(1)
|
2015-04-02
|
2015-04-09
|
1250000.0000
|
2015-04-20
|
|
|
NI. 45-106, 2.3(1), NI. 45-106, 2.5(1)
|
2014-03-31
|
2014-04-04
|
3925358.4000
|
2014-04-10
|
|
|
NI. 45-106, 2.3(1)
|
2014-01-28
|
2014-01-28
|
347978.9500
|
2014-02-06
|
|
|
NI. 45-106, 2.3(1)
|
2013-12-30
|
2013-12-30
|
899444.7000
|
2014-01-16
|
|
|
MI. 45-103, s. 3.1(2)
|
2004-12-07
|
2004-12-07
|
30000.0000
|
2005-01-10
|
Exemption Orders
Nothing on File